H-1B sponsorship profile: Catalent Pharma Solutions. Across U.S. Department of Labor LCA disclosures, Catalent Pharma Solutions filed 213 Labor Condition Applications covering 213 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 87.8% (187 certified of 213 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Catalent Pharma Solutions’s H-1B petitions range from $53,040 at the low end to $450,000 at the high end, with a petition-weighted average of $104,992. That range reflects the mix of occupations the company sponsors, led by Technician, Biomanufacturing, Downstream/mRNA (13 petitions at $54,080 avg), followed by Manufacturing Technical Operations Specialist and Process Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Catalent Pharma Solutions is headquartered in Somerset, NJ under NAICS code 54171, and places H-1B workers across 11 states, most heavily in MD, WI, IN. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.